Objective: To summarize and analyze the compatibility laws and the characteristics of acupoint selection in the treatment of gout by acupuncture over the past 16 years.

Methods: "Gout" and "acupuncture" or "electroacupuncture" were used as search terms in the CNKI, VIP, Wanfang and PubMed databases to retrieve relevant literature. The frequency of the main acupoints and auxiliary acupoints were summarized, respectively. Association rule and hierarchical clustering analysis were used to analyze the possible rules for selecting the main acupoints.

Results: One hundred and eighteen studies met the inclusiven criteria, and involved 67 main acupoints with a frequency of all points of 630. The most commonly used acupoints were Sanyinjiao (SP 6), point, Zusanli (ST 36), Yinlingquan (SP 9), and Taichong (LR 3). The main acupoints mainly belonged to the Spleen Meridian of Foot-, Stomach Meridian of Foot- and Liver Meridian of Foot-. Association rule analysis showed that point, Zusanli (ST 36) and Sanyinjiao (SP 6) had the highest correlation of all the selected acupoints. The cluster analysis showed five core clustering groups.

Conclusions: Acupuncture treatment of gout focuses on acupoints along meridians and the acupoints around the affected joint. The main principles in the treatment of gout are invigorating Spleen, tonifying Kidney, dissipating dampness, resolving blood stasis, clearing away heat, removing toxic substances, soothing Liver, regulating qi, dredging collaterals and relieving pain.

Download full-text PDF

Source
http://dx.doi.org/10.13702/j.1000-0607.2017.06.018DOI Listing

Publication Analysis

Top Keywords

treatment gout
16
main acupoints
12
meridian foot-
12
characteristics acupoint
8
acupoint selection
8
selection treatment
8
acupoints
8
association rule
8
point zusanli
8
main
5

Similar Publications

The deposition of monosodium urate (MSU) crystals within joint spaces produces a painful inflammatory condition known as gout, a specific form of arthritis. The condition calls for a combined curative and preventive management model. A new development in the approach to gout is that of NLRP3-targeted biologic agents, such as monoclonal therapies, to provide more accurate treatment by blocking specific pro-inflammatory cytokines.

View Article and Find Full Text PDF

Monosodium urate crystal accumulation in the joints is the cause of gout, an inflammatory arthritis that is initiated by elevated serum uric acid levels. It is the most prevalent form of inflammatory arthritis, affecting millions worldwide, and requires effective treatments. The necessity for alternatives with fewer side effects is underscored by the frequent adverse effects of conventional therapies, such as urate-lowering drugs.

View Article and Find Full Text PDF

Introduction: The efficacy, safety, optimal timing, and urate-lowering effects of surgical interventions in gout management remain poorly understood. This study aims to fill this gap by evaluating the role of surgery in treating gout patients with tophi.

Method: A retrospective analysis was conducted on 28 gout patients presenting with tophi.

View Article and Find Full Text PDF

Indonesia is still the second-highest tuberculosis burden country in the world. The antituberculosis adverse drug reaction and adherence may influence the success of treatment. The objective of this study is to define the model for predicting the adherence in tuberculosis patients, based on the increased level of liver enzymes.

View Article and Find Full Text PDF

Frailty is an increasingly recognised complication of diabetes in older people and should be taken into consideration in management plans, including the use of the new therapies of sodium glucose cotransporter-2 (SGLT-2) inhibitors and glucagon like peptide-1 receptor agonists (GLP-1RA). The frailty syndrome appears to span across a spectrum, from a sarcopenic obese phenotype at one end, characterised by obesity, insulin resistance, and prevalent cardiovascular risk factors, to an anorexic malnourished phenotype at the other end, characterised by significant weight loss, reduced insulin resistance, and less prevalent cardiovascular risk factors. Therefore, the use of the new therapies may not be suitable for every frail older individual with diabetes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!